NCT02049905 2024-06-13Phase 3 Study to Treat Patients With Soft Tissue SarcomasImmunityBio, Inc.Phase 3 Completed433 enrolled 10 charts
NCT02677116 2020-05-20A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With CancerEli Lilly and CompanyPhase 1 Completed68 enrolled 26 charts